Achievement of long-term treatment goals with upadacitinib in patients with moderately to severely active ulcerative colitis: A post-hoc analysis of INDUCTION and MAINTENANCE phase 3 trials
In this medfyle
Endoscopic healing, and normalization of quality of life should be considered the long-term goals of UC treatment. This post-hoc analysis of INDUCTION and MAINTENANCE trial data assessed the extent to which patients with moderately to severely active UC treated with upadacitinib can achieve and maintain stringent long-term treatment goals after one year of maintenance therapy.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
This is a summary of a presentation given at the UEG Week 2023.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content.
©2023 Infomedica-Medfyle. All rights reserved.
